Atlas Trials

Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis

Clinical trial NCT00004829 · COMPLETED

Trial details

NCT number
NCT00004829
Sponsor
FDA Office of Orphan Products Development
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cystic FibrosisBacterial Infection
Start date
1995-06-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.